Dr. Susanna Mora Francies, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 273 W Uwchlan Ave, Downingtown, PA 19335 Phone: 610-873-4748 |
Dennis P Kerr, ED.M. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 455 Boot Rd, Downingtown, PA 19335 Phone: 484-237-5296 |
Dr. Kathleen Joyce West, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 506 E Lancaster Ave, Lower Level West, Downingtown, PA 19335 Phone: 610-518-6020 |
Ian Glickman, PH.D. Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 519 Larkins Bridge Dr, Downingtown, PA 19335 Phone: 610-458-9135 |
Dr. Hema Dhanvantrai Babaria, PH.D Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 151 Woodbine Rd, Downingtown, PA 19335 Phone: 610-269-2600 |
Valerie Vogel Ross, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2734 Fynamore Ln, Downingtown, PA 19335 Phone: 484-288-8060 |
Luke Bieber, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 21 E Lancaster Ave, Downingtown, PA 19335 Phone: 610-295-5199 |
Ashley Gilbert Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 151 Woodbine Rd, Downingtown, PA 19335 Phone: 888-993-8895 |
Mrs. Jane Elizabeth Compton-wendel, MA Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 410 Boot Rd, Downingtown, PA 19335 Phone: 610-873-1010 Fax: 610-873-9307 |
Mr. Robert Carson Keller Jr., LICENSED PSYCOLOGIST Psychologist Medicare: Not Enrolled in Medicare Practice Location: 455 Boot Rd, Downingtown, PA 19335 Phone: 484-237-5000 |
Richard Mahr, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 151 Woodbine Rd, Downingtown, PA 19335 Phone: 610-269-2600 Fax: 610-518-2020 |
Dr. Naijian Zhang, PH.D Psychologist Medicare: Medicare Enrolled Practice Location: 101 Manor Ave, Downingtown, PA 19335 Phone: 484-883-1116 Fax: 484-696-4435 |
Krista Trainer Psychologist Medicare: Not Enrolled in Medicare Practice Location: 455 Boot Rd, Downingtown, PA 19335 Phone: 484-237-5324 |
Dr. Noelle Jessica Stewart, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 273 W Uwchlan Ave, Downingtown, PA 19335 Phone: 610-873-4748 |
Theresa Counihan Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 601 Dogwood Dr, Downingtown, PA 19335 Phone: 267-918-8713 |
Jackie Bryant Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 455 Boot Rd, Downingtown, PA 19335 Phone: 484-237-5000 |
Dr. Kathleen Mary Quinlisk, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 506 E Lancaster Ave, Downingtown, PA 19335 Phone: 610-518-6020 |
Stacey Mellinger, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 455 Boot Rd, Downingtown, PA 19335 Phone: 484-237-5035 |
Fatuma Dzilala Psychologist Medicare: Not Enrolled in Medicare Practice Location: 401 Mercer Dr, Downingtown, PA 19335 Phone: 484-639-7064 |
Joseph Roscoe Cowell, MA Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 520 E Lancaster Ave, Downingtown, PA 19335 Phone: 610-873-1010 Fax: 610-873-9307 |
News Archive
Pregnant women should take extra precautions amid the coronavirus pandemic. A new study shows that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), attacks the placenta.
Neoadjuvant erlotinib benefits selected epidermal growth factor receptor (EGFR)-mutated patients who undergo complete resection of stage IIIA-N2 stage non-small cell lung cancer(NSCLC), shows a randomized study comparing erlotinib with gemcitabine plus cisplatin as neoadjuvant treatment, presented at the ESMO 2018 Congress in Munich.
Federal health IT officials said Wednesday that the proposed rules for the second stage of the federal program to fund electronic health records will be released Thursday. Office of the National Coordinator Director Farzad Mostashari and other top officials made the announcement at the Healthcare Information and Management Systems Society conference in Las Vegas to two ballrooms packed full of people who had hoped to see the details earlier this week.
AbbVie, a research-based global biopharmaceutical company, today announced it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for the treatment of newly diagnosed patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.
Bio-Path Holdings, Inc., a publicly traded biotechnology company with drug development operations in Houston, Texas, announced today that the U.S. Food and Drug Administration has allowed an IND (Investigational New Drug) for the Company's lead cancer drug candidate liposomal Grb-2 to proceed into clinical trials.
› Verified 3 days ago